47 related articles for article (PubMed ID: 24845569)
1. A positive feedback regulation of ISL-1 in DLBCL but not in pancreatic β-cells.
Zhang Q; Yang Z; Wang W; Guo T; Jia Z; Ma K; Zhou C
Biochem Biophys Res Commun; 2014 Jul; 449(3):295-300. PubMed ID: 24845569
[TBL] [Abstract][Full Text] [Related]
2. ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.
Zhang Q; Yang Z; Jia Z; Liu C; Guo C; Lu H; Chen P; Ma K; Wang W; Zhou C
Mol Cancer; 2014 Jul; 13():181. PubMed ID: 25070240
[TBL] [Abstract][Full Text] [Related]
3. ISL-1 promotes pancreatic islet cell proliferation by forming an ISL-1/Set7/9/PDX-1 complex.
Yang Z; Zhang Q; Lu Q; Jia Z; Chen P; Ma K; Wang W; Zhou C
Cell Cycle; 2015; 14(24):3820-9. PubMed ID: 26176407
[TBL] [Abstract][Full Text] [Related]
4. Islet-1 Is essential for pancreatic β-cell function.
Ediger BN; Du A; Liu J; Hunter CS; Walp ER; Schug J; Kaestner KH; Stein R; Stoffers DA; May CL
Diabetes; 2014 Dec; 63(12):4206-17. PubMed ID: 25028525
[TBL] [Abstract][Full Text] [Related]
5. LIM-homeodomain transcription factor Isl-1 mediates the effect of leptin on insulin secretion in mice.
Chen J; Fu R; Cui Y; Li YS; Pan JR; Liu JL; Luo HS; Yin JD; Li DF; Cui S
J Biol Chem; 2013 Apr; 288(17):12395-405. PubMed ID: 23504315
[TBL] [Abstract][Full Text] [Related]
6. Elevation of transcription factor Islet-1 levels in vivo increases β-cell function but not β-cell mass.
Liu J; Walp ER; May CL
Islets; 2012; 4(3):199-206. PubMed ID: 22595886
[TBL] [Abstract][Full Text] [Related]
7. Antisense miR-7 impairs insulin expression in developing pancreas and in cultured pancreatic buds.
Nieto M; Hevia P; Garcia E; Klein D; Alvarez-Cubela S; Bravo-Egana V; Rosero S; Damaris Molano R; Vargas N; Ricordi C; Pileggi A; Diez J; Domínguez-Bendala J; Pastori RL
Cell Transplant; 2012; 21(8):1761-74. PubMed ID: 22186137
[TBL] [Abstract][Full Text] [Related]
8. LIM-homeodomain transcription factor Isl-1 mediates kisspeptin's effect on insulin secretion in mice.
Chen J; Fu R; Cui Y; Pan J; Li Y; Zhang X; Evans SM; Cui S; Liu J
Mol Endocrinol; 2014 Aug; 28(8):1276-90. PubMed ID: 24956377
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation.
Valleley EM; Cordery SF; Carr IM; MacLennan KA; Bonthron DT
Genes Chromosomes Cancer; 2010 May; 49(5):480-6. PubMed ID: 20175198
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
[TBL] [Abstract][Full Text] [Related]
11. Splenic large B-cell lymphoma in patients with hepatitis C virus infection.
Takeshita M; Sakai H; Okamura S; Oshiro Y; Higaki K; Nakashima O; Uike N; Yamamoto I; Kinjo M; Matsubara F
Hum Pathol; 2005 Aug; 36(8):878-85. PubMed ID: 16112004
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. LIM-homeodomain transcription factor, Lhx2, is involved in transcriptional control of brain-specific promoter/exon 1f of the mouse aromatase gene.
Honda S; Kozako T; Shimeno H; Soeda S; Harada N
J Neuroendocrinol; 2012 Nov; 24(11):1367-74. PubMed ID: 22734700
[TBL] [Abstract][Full Text] [Related]
14. MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.
Perry AM; Alvarado-Bernal Y; Laurini JA; Smith LM; Slack GW; Tan KL; Sehn LH; Fu K; Aoun P; Greiner TC; Chan WC; Bierman PJ; Bociek RG; Armitage JO; Vose JM; Gascoyne RD; Weisenburger DD
Br J Haematol; 2014 May; 165(3):382-91. PubMed ID: 24506200
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
[TBL] [Abstract][Full Text] [Related]
16. [Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma].
Zhang HW; Chen ZW; He JX; Zheng YP; Han WE; Zhao ZQ; Bai W; Wang JF
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):119-23. PubMed ID: 23714666
[TBL] [Abstract][Full Text] [Related]
17. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
18. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-7a inhibits Isl1 expression to regulate insulin secretion by targeting Raf1 and Mapkap1 in NIT-1 cells.
Liu H; Zhang D; Zhou Y; Cui S
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):817-824. PubMed ID: 34713362
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus potentiates diffuse large B‑cell lymphoma via high levels of CCL5.
Zhang J; Luo J; Liu F; Wu D; Zhong Q; Zeng L; Wu Z; Zhao T; Wu L; Hao H
Mol Med Rep; 2014 Sep; 10(3):1231-6. PubMed ID: 24938715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
